Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimal Dose of Surfactant for Preterm Infants With Respiratory Distress Syndrome(RDS)

NCT04984057 is registered in ClinicalTrials.gov with Daping Hospital and the Research Institute of Surgery of the Third Military Medical University as lead sponsor.

NCT NCT04984057
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04984057 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimal Dose of Surfactant for Preterm Infants With Respiratory Distress Syndrome(RDS)
Lead sponsor
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Phase
Not applicable
Overall status
Unknown status
Start date
August 1, 2021
Completion date
December 31, 2024
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bronchopulmonary dysplasia, patent ductus arteriosus, preterm, respiratory distress syndrome, newborn